DIOD Maker of Eco-Friendly Equipment and Nutrition Past Earnings Performance
Past criteria checks 4/6
DIOD Maker of Eco-Friendly Equipment and Nutrition has been growing earnings at an average annual rate of 486.3%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 12.6% per year. DIOD Maker of Eco-Friendly Equipment and Nutrition's return on equity is 7.4%, and it has net margins of 15.1%.
Key information
486.3%
Earnings growth rate
476.8%
EPS growth rate
Pharmaceuticals Industry Growth | 12.4% |
Revenue growth rate | 12.6% |
Return on equity | 7.4% |
Net Margin | 15.1% |
Last Earnings Update | 30 Jun 2021 |
Recent past performance updates
No updates
Revenue & Expenses Breakdown
How DIOD Maker of Eco-Friendly Equipment and Nutrition makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 21 | 607 | 91 | 253 | 0 |
31 Mar 21 | 562 | 64 | 253 | 0 |
31 Dec 20 | 517 | 37 | 254 | 0 |
30 Sep 20 | 528 | 26 | 278 | 0 |
30 Jun 20 | 539 | 16 | 303 | 0 |
31 Mar 20 | 599 | 40 | 303 | 0 |
31 Dec 19 | 658 | 64 | 303 | 0 |
30 Sep 19 | 689 | 56 | 310 | 0 |
30 Jun 19 | 721 | 47 | 316 | 0 |
31 Mar 19 | 748 | 29 | 344 | 0 |
31 Dec 18 | 774 | 11 | 371 | 0 |
30 Sep 18 | 755 | -11 | 404 | 0 |
30 Jun 18 | 736 | -33 | 436 | 0 |
31 Mar 18 | 769 | -26 | 441 | 0 |
31 Dec 17 | 802 | -19 | 447 | 0 |
30 Sep 17 | 841 | -13 | 416 | 0 |
30 Jun 17 | 867 | 0 | 381 | 0 |
31 Mar 17 | 877 | -70 | 369 | 0 |
31 Dec 16 | 886 | -141 | 357 | 0 |
30 Sep 16 | 954 | -163 | 465 | 0 |
30 Jun 16 | 1,022 | -186 | 574 | 0 |
31 Mar 16 | 993 | -153 | 632 | 1 |
31 Dec 15 | 964 | -120 | 690 | 2 |
Quality Earnings: DIOD has high quality earnings.
Growing Profit Margin: DIOD's current net profit margins (15.1%) are higher than last year (2.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DIOD has become profitable over the past 5 years.
Accelerating Growth: Insufficient data to compare DIOD's past year earnings growth to its 5-year average.
Earnings vs Industry: DIOD earnings growth over the past year (486.3%) exceeded the Pharmaceuticals industry 2.8%.
Return on Equity
High ROE: DIOD's Return on Equity (7.4%) is considered low.